93 participants
Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2014-12-23
- Start Date:
- 2004-03-31
- Completion:
- 2012-10-31
Conditions
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
- Nodal Marginal Zone Lymphoma
- Recurrent Adult Diffuse Large Cell Lymphoma
- Recurrent Adult Diffuse Mixed Cell Lymphoma
- Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
- Recurrent Grade 1 Follicular Lymphoma
- Recurrent Grade 2 Follicular Lymphoma
- Recurrent Grade 3 Follicular Lymphoma
- Recurrent Mantle Cell Lymphoma
- Recurrent Marginal Zone Lymphoma
- Refractory Plasma Cell Myeloma
- Splenic Marginal Zone Lymphoma
- Waldenstrom Macroglobulinemia
Interventions
- DRUG
- OTHER
No Results Yet